Transverse Leukonychia And Beau Lines Following COVID-19 Vaccination

August 2022 in “ Cutis ”

Karen Lam, Elizabeth Yim

Studysummary This article suggests that nail abnormalities might occur temporarily after COVID-19 vaccination, but they are self-limiting and should not deter individuals from getting vaccinated.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document discussed that nail abnormalities, such as transverse leukonychia and Beau lines, were observed as potential temporary and self-limiting adverse effects following COVID-19 vaccination. These changes were considered general and not severe enough to discourage individuals from receiving the vaccine, especially given the global efforts to control the pandemic.

View this study on cdn.mdedge.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Case of De Novo Nail Psoriasis Triggered by the Second Dose of Pfizer-BioNTech BNT162b2 COVID-19 Messenger RNA Vaccine

28 citations , September 2021 in “JAAD Case Reports”

This study reports that the Pfizer-BioNTech COVID-19 vaccine showed 52% protection against COVID-19 after the first dose and 95% after the second in phase 3 trials.

research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection

7 citations , June 2021 in “JAAD Case Reports”

This article reviews the cutaneous manifestations of COVID-19, highlighting their potential as early indicators of infection, and reports no new clinical results.

research Heterogeneous Red-White Discoloration of the Nail Bed and Distal Onycholysis in a Patient with COVID-19

8 citations , May 2021 in “Journal of the European Academy of Dermatology and Venereology”

This case report describes a 23-year-old male patient with nail discoloration that may be associated with COVID-19, suggesting possible microvascular damage.